Loading…
Krsnaa Diagnostics (KRSNAA)₹493.60+1.70%Healthcare Service Provider
At the end of the Jun 2026 quarter, Krsnaa Diagnostics' shareholders were: promoters 27.10%, FIIs 4.24%, DIIs 14.52%, public 54.14%. Promoter holding is unchanged on the quarter. FII holding is up 0.87 percentage points from 3.37% a year earlier. It had 53,650 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.78% | 27.02% | 27.02% | 27.16% | 27.16% | 27.23% | 27.23% | 27.10% | 27.10% | 27.10% | 27.10% | 27.10% |
| FIIs | 3.65% | 3.41% | 3.31% | 3.30% | 3.60% | 4.00% | 3.52% | 3.37% | 3.63% | 4.13% | 3.87% | 4.24% |
| DIIs | 18.74% | 16.60% | 15.38% | 15.27% | 15.87% | 14.47% | 14.27% | 14.25% | 14.97% | 13.86% | 13.90% | 14.52% |
| Public | 49.83% | 52.97% | 54.29% | 54.27% | 53.37% | 54.30% | 54.98% | 55.28% | 54.30% | 54.91% | 55.13% | 54.14% |
| Number of shareholders | 60,693 | 57,258 | 56,484 | 55,940 | 53,544 | 52,823 | 53,584 | 54,287 | 52,141 | 52,404 | 53,046 | 53,650 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Rajendra Khivraj Mutha | Promoter | 24.77% | 0.00 |
| Phi Capital Trust - Phi Capital Growth Fund - I | Public | 15.42% | 0.00 |
| Tata Mutual Fund - Tata Small Cap Fund | DII | 8.10% | 0.00 |
| Krsna Diagnostics (Mumbai) Private Limited | Promoter | 2.35% | 0.00 |
| Amicorp Capital (Mauritius) Limited | FII | 2.17% | 0.00 |
| Hdfc Life Insurance Company Limited | DII | 2.06% | 0.00 |
| Bandhan Small Cap Fund | DII | 1.96% | New |
| Medimaze Solutions Private Limited | Public | 1.02% | 0.00 |
| Bandhan Bse Healthcare Index Fund | DII | Exited | — |
Promoters held 27.10% of Krsnaa Diagnostics at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 4.24% (up 0.37 percentage points from 3.87% a quarter earlier) and domestic institutions (DIIs) held 14.52% (up 0.62 percentage points from 13.90% a quarter earlier).
Krsnaa Diagnostics had 53,650 shareholders at the end of the Jun 2026 quarter, against 54,287 a year earlier.
Phi Capital Trust - Phi Capital Growth Fund - I (Public) held 15.42% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.